MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

By M. Boeri, C. Verri, D. Conte, L. Roz, P. Modena, F. Facchinetti, E. Calabró, Carlo Maria Croce, U. Pastorino, G. Sozzi. Proceedings of the National Academy of Sciences of the United States of America, 2011

694 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/73da0b6993a06fdf627c32a8244262ca6e8c9d24

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

Citations in the corpus

MicroRNAs in body fluids—the mix of hormones and biomarkers (2011, neutral): “Recently, a high-throughput study generated miRNA signatures from plasma samples collected 12–28 months before and at the time of lung cancer detection”
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies (2011, background): “themiRNAbiomarkerswe examined,weobserved variation attributable to blood cell effects that was greater in magnitude thanmanyof the differences reported betweenpatients with cancer and controls (13, 15, 20).”
MicroRNAs in stress signaling and human disease (2012, background): “…plasma, saliva, and amniotic fluid (Cortez et al., 2011). miRNAs in serum correlate with the presence of hematologic malignancies and solid tumors and have been reported to be of value for early detection of various types of cancer, preceding diagnosis by conventional methods (Boeri et al., 2011).”
microRNAs in cancer (2013, background): “The presence of miRNAs in serum correlates with the presence of hematologic malignancies and solid tumors and may be valuable for early detection of various types of cancer, preceding diagnosis by conventional methods (57).”